David Melnick
AstraZeneca
5
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Andrew Shaw
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Brendan Smyth
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Ralph Schutz
Quintiles, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Eleanor Lisbon
Quintiles, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Mark Yen, M..D.
California Clinical Trials
Shared therapeutic areas:
Worked with same sponsors:
Mark Yen, MD
Parexel
Shared therapeutic areas:
Worked with same sponsors:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Waqar ahmed awan, Phd
Riphah International University
Shared therapeutic areas:
David Meeker, MD
Rhythm Pharmaceuticals, Inc.
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days
AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days
Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
All 5 trials loaded